Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections

NCT04350580 is registered in ClinicalTrials.gov with Centre Hospitalier St Anne as lead sponsor.

NCT NCT04350580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04350580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Lead sponsor
Centre Hospitalier St Anne
Phase
Phase 3
Overall status
Completed
Start date
April 11, 2020
Completion date
February 20, 2021
Enrollment
146 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19